Advertisement

Amphetamine toxicity: behavioral and neuropathological indexes

  • Charles R. Schuster
  • Marian W. Fischman
Part of the FASEB Monographs book series (FASEBM, volume 4)

Abstract

Toxicology, a science that “deals with poisons and their effects” (43), has traditionally emphasized the identification and analysis of chemicals that interfere with life processes. As techniques became more sophisticated, evaluation of morphological lesions came within the province of toxicologists. Only recently, however, has the possibility of correlating function and morphology been suggested to the student in toxicology (e.g., 42); he has been instructed to critically evaluate chemically induced physiological, biochemical and morphological changes. The indexes of toxicity have usually been alterations in blood and urine chemistry, body temperature, and the like. Many of these physiological changes may be the effect of irreversible morphological pathology, and therefore, in fact, indicative of life-threatening toxicity. These irreversible changes represent an end point in the development of overt indications of toxicity. It is of the utmost importance to be able to detect less obvious, but still destructive damage. What is needed are a series of sensitive measures that might, together or separately, indicate the presence of a potentially poisonous substance.

Keywords

Rhesus Monkey Lever Press Chronic Amphetamine Amphetamine Abuse Chronic Regimen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amarose, A. P., C. R. Schuster and T. P. Muller. An animal model for the evaluation of drug-induced chromosome damage. Oncology 27: 550–562, 1973.PubMedCrossRefGoogle Scholar
  2. 2.
    Angrist, B. M., and S. Gershon. Amphetamine abuse in New York City-1966–1968. Semin. Psychiatry 1: 195–207, 1969.Google Scholar
  3. 3.
    Bradley, P. M., and B. J. Key. The effect of drugs on the arousal responses produced by electrical stimulation of the reticular formation of the brain. Electro-encephalogr. Clin. Neurophysiol. 10: 97–110, 1958.CrossRefGoogle Scholar
  4. 4.
    Chance, M. Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice. J. Pharmacol Exp. Ther. 87: 214–219, 1946.PubMedGoogle Scholar
  5. 5.
    Chance, M. Factors influencing the toxicity of sympathomimetic amines to solitary mice. J. Pharmacol. Exp. Ther. 89: 289–296, 1947.PubMedGoogle Scholar
  6. 6.
    Citron, B. P., M. Halpern, M. Mccarron, G. D. Lundberg, R. Mccor-Mick, I. J., Pincus, D. Tatter and B. J. Haverback. Necrotizing angiitis associated with drug abuse. N. Engl. J. Med. 283: 1003–1011, 1970.Google Scholar
  7. 7.
    Cohn, S. Abuse of centrally stimulating agents among juveniles in California. In: Symposium on the Abuse of Central Stimulants, edited by F. Sjoquist and M. Tottie. New York: Raven, 1968.Google Scholar
  8. 8.
    Cole, J. N., and A. D. Rudzik. Interaction between amphetamine and sympathomimetic agents on the cardiovascular system. In: Amphetamines and Related Compounds, edited by E. Costa and S. Garattini. New York: Raven, 1970, p. 513–530.Google Scholar
  9. 9.
    Cole, S. O. Experimental effects of amphetamine: supplementary report. Percept. Mot. Skills 31: 223–232, 1970.PubMedCrossRefGoogle Scholar
  10. 10.
    Eble, J. N., and A. D. Rudzik. Interaction between amphetamine and sympathomimetic agents on the cardio-vascular system. In: Amphetamines and Related Compounds, edited by E. Costa and S. Garattini. New York: Raven, 1970, p. 513–530.Google Scholar
  11. 11.
    Ellinwood, E. H. Amphetamine psychosis: A multidimensional process. Semin. Psychiatry 1: 208–226, 1969.Google Scholar
  12. 12.
    Ellinwood, E. H. Emergency treatment of acute reactions to CNS stimulants. J. Psychedelic Drugs 5: 147–151, 1972.CrossRefGoogle Scholar
  13. 13.
    Ellinwood, E. H., and O. D. Escalante. Behavior and histopathological findings during chronic methedrine intoxication. J. Soc. Biol. Psychiatry 2: 27–39, 1970.Google Scholar
  14. 14.
    Ellinwood, E. H., A. Sudilovsky and L. M. Nelson. Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am. J. Psychiatry 130: 1089–1093, 1973.Google Scholar
  15. 15.
    Escalante, O. D., and E. H. Ellinwood. Central nervous system cytopathological changes in cats with chronic methedrine intoxication. Brain Res. 21: 555, 1970.Google Scholar
  16. 16.
    Feinberg, G., and S. Irwin. Effects of chronic methamphetamine administration in the cat. Federation Proc. 20: 396, 1961.Google Scholar
  17. 17.
    Ferster, C. B., and B. F. Skinner. Schedules of Reinforcement. New York: Appleton-Century-Crofts, 1957.CrossRefGoogle Scholar
  18. 18.
    Fischman, M. W., and T. H. Meikle, Jr. Visual intensity discrimination in cats after serial tectal and cortical lesions. J. Comp. Physiol. Psychol. 59: 193–201, 1965.PubMedCrossRefGoogle Scholar
  19. 19.
    Fischman, M. W., and C. R. Schuster. Tolerance development to chronic metamphetamine intoxication in the rhesus monkey. Pharmacol. Biochem. Behav. 2: 503–508, 1974.PubMedCrossRefGoogle Scholar
  20. 20.
    Fischman, M. W., and C. R. Schuster. Behavioral, biochemical and morphological effects of methamphetamine in the rhesus monkey. In: Behavioral Toxicity, edited by B. Weiss and V. Laties. New York: Plenum, 1975, p. 375–394.CrossRefGoogle Scholar
  21. 21.
    Fitz-Gerald, F. Effects of d-amphetamine upon behavior of young chimpanzees reared under different conditions. In: Neuropsychopharmacology, edited by H. Brill and J. Cole. Amsterdam: Elsevier, 1967, vol. 5, p. 1226.Google Scholar
  22. 22.
    Griffith, J. D., J. Cavanaugh and J. Oates. Schizophreni form psychosis induced by large-dose administration of d-amphetamine. J. Psychedelic Drugs 2: 25–27, 1969.CrossRefGoogle Scholar
  23. 23.
    Harrison, J. W. E., C. M. Ambrus and J. L. Ambrus. Tolerance of rats toward amphetamine and methamphetamine. J. Am. Pharm. Assoc. 41: 539–541, 1952.Google Scholar
  24. 24.
    Herman, Z. S. The influence of prolonged amphetamine treatment and amphetamine withdrawal on brain biogenic amine content and behavior in the rat. Psychopharmacologia 21: 74, 1971.PubMedCrossRefGoogle Scholar
  25. 25.
    Höhn, R., and L. Lasagna. Effects of aggregation and temperature on amphetamine toxicity in mice. Psychopharmacologia 1: 210, 1960.CrossRefGoogle Scholar
  26. 26.
    Johanson, C. E., R. L. Balster and K. F. Bonese. Self-administration of psychomotor stimulant drugs: The effects of unlimited access. Pharmacol. Biochem. Behav. Submitted.Google Scholar
  27. 27.
    Jönsson, L. E., and L. M. Günne. Clinical studies of amphetamine psychosis. In: International Symposium on Amphetamines and Related Compounds, edited by E. Costa and S. Garattini. New York: Raven, 1970, p. 929–936.Google Scholar
  28. 28.
    Kalant, O. J. The amphetamines: Toxicity and addiction. Springfield, 111.: Thomas, 1966.Google Scholar
  29. 29.
    Kasirsky, G., I. H. Zaidi and M. F. Tansy. LD 50 and pathologic effects of acute and chronic administration of methamphetamine HCl in rabbits. Res. Commun. Chem. Pathol. Pharmacol. 3: 215–231, 1972.PubMedGoogle Scholar
  30. 30.
    Kiloh, L. G., and S. Brandon. Habituation and addiction to amphetamines. Br. Med. J. 2: 40–43, 1962.PubMedCrossRefGoogle Scholar
  31. 31.
    Kosman, M. E., and K. R. Unna. Effects of chronic administration of the amphetamines and other stimulants on behavior. J. Clin. Pharmacol. Ther. 9: 240–254, 1968.Google Scholar
  32. 32.
    Kramer, J. C., V. S. Fischman and D. C. Littlefield. Amphetamine abuse. J. Am. Med. Assoc. 201: 305–309, 1967.CrossRefGoogle Scholar
  33. 33.
    Pickens, R., and W. Harris. Self-administration of d-amphetamine by rats. Psychopharmacologia 12: 158–163, 1968.PubMedCrossRefGoogle Scholar
  34. 34.
    Rosenberg, D. E., A. B. Wolbach, E. J. Miner and H. Isbell. Observations on direct and cross tolerance with LSD and ¿-amphetamine in man. Psychopharmacologia 5: 1–15, 1963.PubMedCrossRefGoogle Scholar
  35. 35.
    Rumbaugh, C. L., R. T. Bergeron, R. L. Scanlan, J. S. Teal, H. D. Segall, H. C. H. Fang and R. McCormick. Cerebral vascular changes secondary to amphetamine abuse in the experimental animal. Radiology 101: 345–351, 1971.PubMedGoogle Scholar
  36. 36.
    Schuster, C., W. Dockens and J. Woods. Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia 9: 170–182, 1966.PubMedCrossRefGoogle Scholar
  37. 37.
    Schuster, C. R., and C. E. Johanson. The use of animal models for the study of drug dependence. In: Research Advances in Alcohol and Drug Problems, edited by R. J. Gibbons. New York: Wiley, 1974, p. 1–32.Google Scholar
  38. 38.
    Schuster, C. R., and J. Zimmerman. Timing behavior during prolonged treatment with d, J-amphetamine. J. Exp. Anal. Behav. 4: 327–330, 1961.PubMedCrossRefGoogle Scholar
  39. 39.
    Smith, D. E. The characteristics of dependence in high-dose methamphetamine abuse. Int. J. Addict. 4: 453–459, 1969.Google Scholar
  40. 40.
    Smith, D. E., and C. M. Fischer. An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury. Clin. Toxicol. 3: 117–124, 1970.PubMedCrossRefGoogle Scholar
  41. 41.
    Tormey, J., and L. Lasagna. Relation of thyroid function to acute and chronic effects of amphetamine in the rat. J. Pharmacol. Exp. Ther. 128: 201–209, 1960.PubMedGoogle Scholar
  42. 42.
    Stewart, C. P., and A. Stolman. The toxicologist and his work. In: Toxicology: Mechanisms and Analytical Methods, edited by C. P. Stewart and A. Stolman. New York: Academic, 1960, pp. 1–25.Google Scholar
  43. 43.
    Webster’s Seventh New Collegiate Dictionary. Springfield, Mass.: Merriam, 1967, 936.Google Scholar

Copyright information

© Springer Science+Business Media New York 1975

Authors and Affiliations

  • Charles R. Schuster
    • 1
    • 2
  • Marian W. Fischman
    • 1
    • 2
  1. 1.Department of PsychiatryUniversity of Chicago Pritzker School of MedicineChicagoUSA
  2. 2.Department of Pharmacological and Physiological SciencesUniversity of Chicago Pritzker School of MedicineChicagoUSA

Personalised recommendations